ALD-301 for Critical Limb Ischemia, Randomized Trial

Clinical trial NCT00392509 · COMPLETED

Trial details

NCT number: NCT00392509
Sponsor: Aldagen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia Peripheral Arterial Disease Peripheral Vascular Disease

Start date: 2006-10-01
Primary completion: 2008-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.